*Staphylococcus aureus*, a commensal of the skin and nares, is the cause of infections ranging from uncomplicated skin infections to serious complicated infections such as pneumonia, osteomyelitis, endocarditis, and sepsis \[[@OFV093C1]--[@OFV093C3]\]. The ability of *S aureus* to cause severe infections is attributed to its repertoire of virulence factors, many of which are transferred horizontally through the *S aureus* community \[[@OFV093C4], [@OFV093C5]\]. *Staphylococcus aureus* isolates are classified into different genetic lineages or clonal complexes (CCs) based on genome content, with a close association between bacterial genetic characteristics and the distinct clinical manifestations \[[@OFV093C6]--[@OFV093C12]\]. There are over 100 CCs of *S aureus*, and CC5, CC8, CC22, CC30, and CC45 are more frequently associated with hospital-acquired infections. *Staphylococcus aureus* CC30 is the major nasal carriage lineage, and it is associated with the majority of autologous infections \[[@OFV093C13]\]. Previous work from our group \[[@OFV093C8], [@OFV093C14], [@OFV093C15]\] demonstrated that the CC30 lineage is associated with hematogenous complications, including endocarditis, septic arthritis, and vertebral osteomyelitis. In addition, CC30 is more frequently associated with persistent versus resolving bacteremia, and it shows increased adhesion to endothelial cells, elevated resistance to human neutrophil peptide hNP-1, and increased membrane fluidity compared with resolving strains \[[@OFV093C16]\]. These attributes of CC30 isolates may potentially be responsible for invasion of endocardial surfaces and contribute to persistent infection. The genomic basis for these CC30 characteristics is unknown.

In the current investigation, we used in vivo sepsis models, comparative genomics, and RNA-Seq transcriptome analysis of CC30 and other CCs to (1) evaluate virulence and severity of infections and (2) identify genomic features that contribute to CC30 persistence and complicated infections. *Staphylococcus aureus* CC30 isolates were significantly less virulent compared with other CCs. The attenuated virulence of CC30 isolates in sepsis models is attributed to its distinct genomic architecture, single-nucleotide polymorphisms (SNPs) that inactivate key virulence genes, and differential regulation of metabolic and adhesin genes.

MATERIALS AND METHODS {#s2}
=====================

All animal research was approved by Duke University Institutional Review Board and Institutional Animal Care & Use Committee, as appropriate. Genome sequence and assembly, assembly validation using Opgen optical maps, genome annotation, whole-chromosome phylogenetic analysis, Jaccard Orthologous Clustering (JOC) analysis, and SNP discovery and analysis in CC30 strains are described in [Supplementary Materials and Methods](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1).

*Staphylococcus aureus* Clinical Isolates {#s2a}
-----------------------------------------

The 379 *S aureus* isolates (125 methicillin-resistant *S aureus* \[MRSA\] and 254 methicillin-sensitive *S aureus* \[MSSA\] isolates from CC1, CC5, CC8, CC5, CC30, and CC45) used for our initial genotypic multilocus sequence typing \[MLST\]/Spa typing were selected using strict definitions to identify 3 clinical groups that represent a progression from healthy individuals to those who are severely infected: (1) nasal carriage only (healthy controls), (2) uncomplicated infection, and (3) bacteremia with hematogenous complications \[[@OFV093C8]\]. Multiple levels of array-comparative genomic hybridization analyses identified differences in gene content relative to CC, MRSA, and MSSA status as well as clinical outcome. Two separate analyses, one dependent on CC status (found in CC5 and CC30) and a second independent of CC status, identified an identical set of 14 genes associated with complicated infections \[[@OFV093C8], [@OFV093C14]\]. The 29 MRSA isolates in the Complicated Infection Group (CIG) (Table [1](#OFV093TB1){ref-type="table"}) used in the current study were selected from the initial 379 *S aureus* isolates based on (1) carriage and clinical severity, (2) MRSA status, (3) presence and proportion of the 14 candidate virulence genes, and (4) CC. The CC30 CIG isolates belong to the previously described contemporary CC30 clone lineage that diverged from the phage-type 80/81 *S aureus* clone \[[@OFV093C17]--[@OFV093C19]\]. Table 1.Methicillin-Resistant *Staphylococcus aureus* Strains in the CIGID^a^Clonal ComplexGroupB&JEndoBothOutcome^b^Proportion^c^10575ComplicatedX1110965ComplicatedX20.911505ComplicatedX10.36411655ComplicatedX30.9212135ComplicatedX30.9217505ComplicatedX3117695ComplicatedX30.716128ComplicatedX10.811148ComplicatedX10.555478ComplicatedX10.8620188ComplicatedX10.75152445ComplicatedX30.329045ComplicatedX20.5618351ComplicatedX30.88117630ComplicatedX10.93124230ComplicatedX10.93150030ComplicatedX31160530ComplicatedX20.92126730ComplicatedX11121430ComplicatedX30.914930ComplicatedX30.9123330ComplicatedX3117708ComplicatedX30.58C34D8Nasal carriage0.2C34D5Nasal carriage0.2C3485Nasal carriage1C34D30Nasal carriage1C9315Nasal carriage0.1C1281Nasal carriage0.6[^2][^3][^4][^5][^6]

*Staphylococcus aureus* Reference Strains for Comparative Genome and Transcriptome Analysis {#s2b}
-------------------------------------------------------------------------------------------

*Staphylococcus aureus* MRSA252 (a reference strain for the contemporary CC30 MRSA-16 lineage \[[@OFV093C20]\]), N315 (a CC5 reference strain \[[@OFV093C21]\]), THC60 (an *S aureus* CC30 isolate sequenced in the Human Microbiome Project \[PRJNA159859\]), and UAMS-1 (a commonly used clinical CC30 strain from an osteomyelitis patient \[[@OFV093C22]\]) were obtained from Network on Antimicrobial Resistance in *Staphylococcus aureus* or Mark Smeltzer (University of Arkansas).

Preparation of *Staphylococcus aureus* Cells {#s2c}
--------------------------------------------

To prepare *S aureus* cells for injection, an isolated colony from a fresh tryptic soy agar (TSA) plate was inoculated to 10 mL fresh tryptic soy broth and incubated at 37°C/220 revolutions per minute (rpm) for overnight culture. An appropriate amount of overnight bacterial culture was added to 100 mL fresh tryptic soy broth (TSB) in a 500 mL Erlenmeyer flask to normalize the initial optical density (\[OD\] 600) to approximately 0.1. The flasks were incubated at 37°C/220 rpm to log-phase growth (OD 600 ∼ 1.0). *Staphylococcus aureus* cells were harvested by centrifugation, washed twice with phosphate-buffered saline (PBS), resuspended in PBS containing 20% glycerol to a concentration of approximately 10^6^ colony-forming units (CFUs)/µL, aliquoted into individual cryovials, and immediately stored at −80°C until further use. An aliquot of PBS-washed culture was serially diluted and plated on TSA plates to enumerate CFUs. Frozen stocks were titered for CFUs in triplicate on separate occasions before use in any experiment.

Mouse Model of Intraperitoneal Sepsis {#s2d}
-------------------------------------

Six- to 8-week-old C57BL/6J mice used in this study were purchased from The Jackson Laboratory (Bar Harbor, ME). Colony-forming units (10^8^) of each *S aureus* strain in 200 µL suspension in PBS were injected intraperitoneally into 5 mice in each experimental group. Mice were given supplemental care and observed continuously for survival for 8 hours postinfection and then every day for 5 days.

Wax Moth Model of Sepsis {#s2e}
------------------------

The wax moth model of sepsis (described previously \[[@OFV093C23], [@OFV093C24]\]) was used in this study with slight modifications. In brief, the larval form of greater wax moth (*Galleria mellonella*) was purchased from Best Bet Inc. (Blackduck, MN) and stored at 4°C in dark until used for the sepsis experiments. The larvae were incubated at room temperature overnight prior to injection with *S aureus*. Twenty healthy larvae of similar size (approximately 250--300 mg) were injected in each experimental group, using 50 µL Hamilton syringes fitted with 26-gauge needles (Hamilton Company, Reno, NV), along with 20 uninjected and PBS-injected controls. The frozen stock of each culture (prepared as described earlier) was thawed on ice and diluted in PBS to the desired number of *S aureus* cells in the inoculum (10 µL of inoculum containing either 10^5^ or 10^6^ CFUs of *S aureus*). The larvae were incubated at 37°C, observed 4 hours postinfection, and then every day for 5 days to monitor survival. Dead larvae were identified as those melanized and unresponsive to stimuli.

RNA-Seq Transcriptome Analysis of Complicated Infection Group Isolates {#s2f}
----------------------------------------------------------------------

Whole transcriptome analysis of the 29 MRSA CIG isolates, MRSA252, N315, and UAMS-1 was determined by RNA-Seq. To prepare isolates for RNA extraction, an overnight culture of *S aureus* was inoculated into 100 mL fresh TSB in a 500 mL Erlenmeyer flask to an OD (600) to approximately 0.1. The flasks were incubated at 37°C/220 rpm to log-phase growth (OD 600 ∼ 0.6). Total RNA was extracted by mechanical lysis in acid phenol \[[@OFV093C25]\], and rRNA was depleted by Ribo-Zero (Illumina, San Diego, CA) and sequenced with Illumina Tru-Seq. Low complexity reads, adapter, and vector contamination were removed using Seqclean (<http://sourceforge.net/projects/seqclean/>) and the National Center for Biotechnology Information (NCBI) UniVec database. Processed reads were then mapped to the MRSA252 genome with SHRiMP version 2.2.3 \[[@OFV093C26]\]. Differential expression analysis was performed using Cufflinks (cuffDiff2) version 2.0.2 \[[@OFV093C27]\] of the general transfer format annotation file for the reference genome and a false discovery rate of 0.05. The RNA expression levels for each gene were expressed as fragments per kilobase per million reads mapped (FPKM). Genes in which all samples did not have at least an FPKM of 1 were removed from consideration before downstream analysis. A greater than log2-fold increase or decrease in expression level was used to identify genes that were significantly different between the CCs. A custom PERL program was used to determine overlap of significant differentially expressed genes between samples within and between the CCs at a variety of levels of agreement (50%, 80%). Heat maps and dendograms were generated by per gene z-score that was computed from log~10~ FPKM values or hierarchical clustering of log~10~ FPKM values. Comparison of whole transcriptome expression between CCs was determined by multidimensional scaling (MDS) of the normalized compression distance. All RNA-Seq data (raw sequence reads and primary analysis) are deposited at NCBI and Sequence Read Archive under BioProject PRJNA255909.

Statistical Analyses {#s2g}
--------------------

For survival analysis in both animal models, the survival data were pooled together into 2 groups (CC30 vs others), and the Kaplan-Meier survival curve was generated using GraphPad Prism, version 5.0 (La Jolla, CA). The survival difference between strains was assessed using the log-rank: Mantel-Cox test. To identify genes uniquely associated with CC30 (Table [1](#OFV093TB1){ref-type="table"}), protein clusters of related function identified using JOC ([Supplementary Table 1](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1)) were first sorted by a *t* test comparison of clusters present in CC30 vs all other CCs. All clusters with *P* \< .05 were then evaluated across all 60 genomes to calculate proportion of genomes containing each cluster (expressed as percentage).

RESULTS {#s3}
=======

Attenuated Virulence of Clonal Complex 30 in Murine and *Galleria mellonella* Sepsis Models {#s3a}
-------------------------------------------------------------------------------------------

When compared with all other CCs studied, CC30 isolates demonstrated significantly attenuated virulence in both the murine intraperitoneal sepsis (*P* \< .0001; Figure [1](#OFV093F1){ref-type="fig"}A) and *G mellonella* sepsis models (*P* \< .0001; Figure [1](#OFV093F1){ref-type="fig"}B). This attenuated virulence of CC30 persisted when alternate infective doses of *S aureus* (10^6^ CFU instead of 10^5^ CFU, data not shown) were used in *G mellonella* sepsis model. Figure 1.(A) Kaplan--Meier survival curve of C57BL/6J mice after infection with *Staphylococcus aureus* in the Complicated Infection Group (CIG). C57BL/6J mice were given intraperitoneal injections with 10^8^ colony-forming units (CFUs) of each CIG *S aureus* isolates (n = 5 mice for each strain). Survival analysis was done using log-rank Mantel-Cox test in GraphPad prism. \*, *P* value (log-rank: Mantel-Cox test); clonal complex (CC) 30 strains include 1176, 1242, 1500, 1605, 1267, 1233, and 1214. Others include CC1 (1835), CC5 (1057, 1096, 1150, 1165, 1213, 1750, 1769), CC8 (1612, 1114, 547, 2018, 1770), and CC45 (1524, 290). (B) Kaplan-Meier survival curve of greater wax moth (*Galleria mellonella*) after infection with *S aureus* in the CIG. The greater wax moth (*G mellonella*) were given injections with 10^5^ CFU of each CIG *S aureus* isolates (n = 20 worms for each strain). Survival analysis was done using log-rank Mantel-Cox test in GraphPad prism. \**P* value (log-rank: Mantel-Cox test); strains used are identical to those in A.

Phylogenetic Relationships Between the Clonal Complexes {#s3b}
-------------------------------------------------------

Phylogenetic information included in the core genome alignments of the 29 CIG isolates and 31 closed *S aureus* genomes available in GenBank were used to determine the genomic relatedness of the CIG isolates. There is significant congruence between the previously determined grouping by MLST into CCs and the current whole-genome phylogeny. As demonstrated by SNP whole-genome alignments (Figure [2](#OFV093F2){ref-type="fig"}) showing phylogenetic relationship between the CCs, all CC30 CIG isolates clustered into the same phylogroup, most closely related to the CC45 and CC398 lineages and most distant from CC5. Figure 2.Maximum likelihood single-nucleotide polymorphism (SNP) tree for 60 *Staphylococcus aureus* isolates, representing relationships between clonal complexes (CCs) in the Complicated Infection Group (CIG) and previously sequenced *S aureus* genomes. Single nucleotide polymorphisms were identified in pairwise genome comparisons between the predicted genes in all genomes. Single nucleotide polymorphisms for each genome were concatenated to form SNP pseudosequences and used to generate a phylogenetic tree using the HKY93 algorithm \[[@OFV093C28]\] with 500 bootstrap replicates.

Jaccard Orthologous Clustering Analysis to Distinguish Genome Features Unique to Clonal Complex 30 Isolates {#s3c}
-----------------------------------------------------------------------------------------------------------

Jaccard Orthologous Clustering analysis is typically used to group together highly similar proteins within a single genome/organism of interest and allows for one-to-many orthology. Comparisons of protein families between the 29 CIG genomes sequenced in this study (Table [1](#OFV093TB1){ref-type="table"}) and 31 additional complete *S aureus* genomes available in the GenBank were used to identify genomic features that distinguished the CC30 lineage from the other predominant lineages. A total of 2300 proteins were present among all tested CCs. The CC30 isolates possessed a distinct set of proteins, including 25 proteins encoded in all CC30 strains and absent in greater than 90% of all other CCs (Table [2](#OFV093TB2){ref-type="table"} and [Supplementary Table 1](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1)). Twenty-six proteins were uniquely associated with CIG CC30 isolates but were absent in CC30 isolates MRSA252 and THC60 (contemporary CC30 reference clones \[[@OFV093C20]\]). Functions of these 26 proteins suggested ongoing evolutionary changes among the CIG isolates. Twenty-eight proteins unique to CC30 were previously identified in islets of the MRSA252 genome \[[@OFV093C20]\]. Table 2.Proteins Identified by Jaccard Orthologous Clustering as Associated with *Staphylococcus aureus* CC30 IsolatesRepresentative Protein ID in Cluster (LOCUS Name)Representative MRSA252 Protein in Cluster (LOCUS Name)Common NameCC30 Average Number of Proteins in Cluster^a^Present in All CC30 Strains and Absent in \>90% of Other CCPresent in \>50% of CC30 and Absent in \>90% of Other CCPresent in CC30 CIG and Absent in MRSA252 or THC60Absent in \>50% of CC30 and Present in \>90% of Other CCAbsent in \>90% of CC30 and Present in \>90% of Other CC*t* Test CC30 vs OthersCIG1176_2319SAR1587^+b^PfkB Carbohydrate Kinase Family Protein1.0X1.97E--30SAR0638SAR0638^+^Hypothetical (Putative Membrane Protein)1.0X1.97E--30CIGC341D_1278SAR0717Bacterial Regulatory Helix-Turn-Helix, LysR Family Protein0.9X1.38E--29CIG1500_1282SAR0721Multicopper Oxidase *mco*0.9X1.38E--29CIG1267_1237SAR0715Glyoxalase0.9X1.38E--29CIG1267_1239SAR0718Conserved Hypothetical 698 Family Protein0.9X1.38E--29CIG1214_1043A^c^Pemk-Like Family Protein0.9X1.38E--29CIG1214_2795APhosphoribosylformylglycinamidine Synthase Subunit PurS0.9X1.38E--29CIG1233_343SAR2591^+^LysE Type Translocator Family Protein1.0X1.09E--22SAR2592SAR2592^+^Fatty Acid Desaturase1.0X1.09E--22HMPREF0772_10409SAR0091^+^Insertion Sequence Protein1.0X1.09E--22CIG1500_1207APutative Inorganic Diphosphatase0.8X4.42E--21CIGC341D_1257APutative Membrane Protein0.8X4.42E--21CIG1267_2996APutative Membrane Protein0.8X4.42E--21CIG1605_2630AFRG Domain Protein0.8X4.42E--21CIG149_1264AHAD Hydrolase, IA, Variant 1 Family Protein0.8X4.42E--21CIG1500_1272AHTH Domain Protein0.8X4.42E--21CIG1267_646SAR0087^+^5-Methylcytosine-Specific Restriction Enzyme B Domain Protein1.0X1.70E--18CIG1500_647SAR0088McrBC 5-Methylcytosine Restriction System Component Family Protein1.0X1.70E--18SATW20_26470AABC Transporter ATP-Binding Protein0.0X1.70E--18SAUSA300_0078SAR0720ATPase Copper Transport0.9X4.96E--17CIG149_961SAR0368DNA Binding , Excisionase Family Domain Protein0.9X4.96E--17SAB0348SAR0372Pathogenicity Island Protein1.8X5.58E--17CIG1769_494AABC-2 Transporter Family Protein0.0X1.01E--15CIGC348_980ABeta-Grasp Domain Toxin Protein0.0X1.01E--15SAA6008_02763SAR2788^+^Hypothetical (Putative Exported Protein)1.0X1.01E--15CIG1176_934SAR2149^+^Hypothetical (Putative Exported Protein)1.0X1.01E--15CIG149_981SAR0383Abi-Like Family Protein1.9X9.77E--15CIG1176_1377SAR0704Bacteriophage CI Repressor Helix-Turn-Helix Domain Protein0.9X2.81E--14CIG1524_2315SAR0697Bacteriocin Export ABC Transporter0.9X2.81E--14ECTR2_1030AHaemolytic Family Protein0.0X1.05E--13CIG1165_915SAR0395Putative Membrane Protein0.4X8.92E--13CIG1605_357ATransposase1.3X8.92E--13CIG149_1454SAR0838^+^Hypothetical (Putative Membrane Protein)1.0X1.05E--13SAA6008_02764SAR2789^+^Subtilase Family Protease0.9X2.60E--12CIG1605_650AAcetyltransferase0.9X2.60E--12CIG1605_1279SAR0723Copper-Translocating P-Type ATPase0.9X2.60E--12CIG290_643AArylamine N-Acetyltransferase Family Protein0.9X2.60E--12SAMSHR1132_23190AHTH-Type Transcriptional Regulator SarU0.0X3.72E--12CIG1605_203SAR2451^+^Bacterial Regulatory S, TetR Family Protein1.0X3.72E--12HMPREF0772_10825SAR2453^+^Multidrug ABC Superfamily ATP Binding Cassette Transporter Permease Protein1.0X3.72E--12CIG1214_1283SAR0696Conserved Hypothetical Family Protein0.8X2.96E--11CIG290_224SAR2452^+^ABC Transporter Family Protein1.0X6.43E--11SAEMRSA15_23960APutative Staphylococcal Accessory Regulator0.0X6.43E--11SAR0097SAR0097^+^DNA-Binding Protein1.0X6.43E--11SATW20_01030SAR0093^+^Hypothetical (Putative Membrane Protein)1.0X6.43E--11CIG1233_404APutative Membrane Protein0.7X1.68E--10M013TW_0379SAR2299Putative Transcriptional Regulator1.0X5.52E--10CIG1176_846SAR0287Putative Transposase1.0X6.68E--10CIG1165_437SAR2683Putative Membrane Protein0.2X9.32E--10CIG1612_299APrevent-Host-Death Family Protein0.1X1.22E--09SAB0782ALeukocidin Chain *lukM* Precursor0.0X4.03E--09CIG290_888AVirulence Factor EsxB Family Protein0.0X4.76E--09HMPREF0772_10238SAR0261^+^Nitric Oxide Reductase1.0X4.76E--09CIG1267_2788AEndodeoxyribonuclease RusA Family Protein0.6X6.03E--09SAR0724SAR0724Cadmium Efflux System Accessory Protein0.9X1.11E--08CIG1233_2758AHelix-Turn-Helix Domain Protein0.8X1.35E--08CIG149_1032AToxic Shock Syndrome Toxin-10.8X1.35E--08CIG1214_1405SAR0824Malic Enzyme, NAD Binding Domain Protein1.0X2.54E--08CIG1176_970AHelix-Turn-Helix Family Protein0.9X7.02E--08CIGC128_313ASurface Protein G0.0XX3.42E--07SAT0131_00223SAR0228^+^Glutamine Amidotransferase Class-I1.0X3.42E--07CIG1176_657SAR0098Acetyltransferase Family Protein1.0X3.84E--07CIG1267_946APhage Integrase Family Protein0.8X6.68E--07CIG1214_965ADNA Binding, Excisionase Family Domain Protein0.8X6.68E--07CIG1835_198SAR2774Collagen Adhesin1.0X1.18E--06CIGC341D_1691ASeryl-tRNA Synthetase0.5X1.59E--06SAA6008_00068SAR0092^+^Amidohydrolase1.0X2.23E--06CIG1057_526APutative Membrane Protein0.0X3.19E--06CIG1233_2421SAR1826ATP-Binding Protein0.9X4.11E--06SAOV_2044ADrug/Metabolite Transporter Permease0.0X7.12E--06CIG290_550SAR2748Intracellular Adhesion Protein D0.2X1.03E--05CIG1057_701ABacterial Transferase Hexapeptide Family Protein0.0XX3.36E--05CIG1769_827AO-Antigen Ligase Family Protein0.0XX3.36E--05ECTR2_116ACapsular Polysaccharide Synthesis Protein Cap5K0.0XX3.36E--05SARLGA251_01310ACapsular Polysaccharide Synthesis Enzyme0.0XX3.36E--05CIGC348_1890AMAP Domain Protein0.0X7.11E--05[^7][^8][^9][^10]

Single-Nucleotide Polymorphisms in Clonal Complex 30 Complicated Infection Group Isolates {#s3d}
-----------------------------------------------------------------------------------------

The CIG genomes were compared with the contemporary CC30 reference strain, MRSA252, and the N315 (CC5) genomes (described in Materials and Methods) to identify specific SNPs potentially associated with unique phenotypic characteristics of the CC30 lineage. When compared with MRSA252, nonsynonymous SNPs were identified among 131 unique open reading frames (ORFs) in the 9 CC30 CIG isolates ([Supplementary Table 2](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1)). Stop codons were identified in 5 unique ORFs, and 42 SNPs were identified in intergenic regions of the CC30 CIG genomes. Thirty-five synonymous and nonsynonymous SNPs were present in all CIG CC30 isolates when compared with MRSA252. Similar to the previous analysis of the historic and contemporary CC30 lineage \[[@OFV093C17]--[@OFV093C20], [@OFV093C29]\], SNPs were identified in the following: (1) *agrC* (G→A) that predicts a Gly-to-Arg substitution at residue 55 (*agrC*~G55R~); (2) *hla*, where a premature stop codon is introduced; and (3) PSMα3, which results in lower cytolytic and chemotactic activity. The ratio of nonsynonymous to synonymous SNPs (90:64 from a total of 154 SNPs) ([Supplementary Table 2](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1)) across all CC30 isolates relative to MRSA252 through the entire genome suggests continuing evolutionary divergence or adaptation in this lineage. Further details of SNPs identified in the CC30 CIG genomes are listed in [Supplementary Table 2](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1).

Transcriptomic Analysis of the Complicated Infection Group Isolates {#s3e}
-------------------------------------------------------------------

To test the hypothesis that transcriptome level differences in the CIG isolates were associated with differences in virulence and fitness, we conducted RNA-Seq whole transcriptome analysis of the 29 CIG isolates, MRSA252, N315, and UAMS-1 (a CC30 osteomyelitis isolate and a commonly used laboratory strain \[[@OFV093C22]\]). Our analysis included the following: (1) identification of strain-specific transcriptional differences within and between CCs (Figures [3](#OFV093F3){ref-type="fig"} and [4](#OFV093F4){ref-type="fig"}) and (2) MDS (Figure [5](#OFV093F5){ref-type="fig"}) of all CIG isolates to evaluate overall transcriptional differences between the CCs. The CC30 CIG clinical isolates and MRSA252 share a common transcriptome, whereas the CC1, CC5, CC8, CC15, and CC45 randomly cluster into 3 distinct transcriptome groups. The transcriptome of UAMS-1 is distinct from the CC30 CIG strains and MRSA252. Genes with higher expression levels in CC30 relative to all other CC examined in our study include protein A (*spa*), multiple putative membrane proteins (SAR2274, SAR2275), and multiple putative exported proteins (SAR2016, SAR0437, and SAR0694). Genes with lower expression levels in CC30 relative to all other CC include the following (Figure [4](#OFV093F4){ref-type="fig"}): (1) several encoding metabolic functions, such as multiple members of the pyrimidine biosynthesis pathway \[Carbamoyl-phosphate synthase large chain(*carB*), Dihydroorotase (*pyrC*), Bifunctional protein(*pyrR*), Orotate phosphoribosyltransferase(*pyrE*), and Orotidine 5′-phosphate decarboxylase(*pyrF*)\]; (2) 3 genes \[ABC transporter extracellular binding protein(SAR0641), ABC transporter permease protein(SAR0642), and ABC transporter ATP-binding protein(SAR0643)\] encoding an operon similar to a *Staphylococcus epidermidis* iron repressible ABC transport system; and (3) an azoreductase (*acpD*). Comparison within the CC30 isolates identified 38 genes (excluding ribosomal proteins and transposases) that are differentially expressed within this CC (data not shown). These are primarily metabolic genes, including genes that participate in lactate metabolism ([l]{.smallcaps}-lactate dehydrogenase \[*ldh1*\] and [l]{.smallcaps}-lactate permease \[*lldP2*\]) and riboflavin biosynthesis (riboflavin biosynthesis protein \[*ribA*\], bifunctional riboflavin biosynthesis protein \[*ribD*\], riboflavin synthase alpha chain \[*ribE*\], and 6,7-dimethyl-8 ribityllumazine synthase \[*ribH*\]). Figure 3.Heat map of RNA-Seq transcriptome analysis for 1259 selected genes from the *Staphylococcus aureus* Complicated Infection Group (CIG) and reference strains. Total RNA was extracted from log-phase cultures (optical density, 600 ∼ 0.6), sequenced, and analyzed as described in Materials and Methods. Genes that were identified as significantly different between the clonal complexes (CCs) had fragments per kilobase per million reads mapped (FPKM) values of at least 1 and a greater than log~2~-fold increase or decrease in expression level. The heat map shows log~10~ FPKM values for 1259 selected genes (rows) and 32 samples (columns). Color corresponds to per-gene z-score that is computed from log~10~ FPKM (after adding 0.01). Genes were omitted from the original list of 2807 if the per-gene variance was less than 0.05 (low-variability genes) or if the FPKM expression was less than 10 for all 32 samples (uniformly, low-expressed genes). Based on these criteria, approximately 45% of the genes are shown. Genes and samples were hierarchically clustered based on Euclidean distance of z-score data and average linkage (dendrogram not shown for genes). Tick marks to the left of the heat map indicate genes in Figure [4](#OFV093F4){ref-type="fig"}. The figure on the right shows data expanded for 13 genes in cluster near top of heat map indicate FPKM expression of genes in CC30 relative to other CCs. Figure 4.Heat map of RNA-Seq transcriptome analysis for 52 selected genes from the *Staphylococcus aureus* Complicated Infection Group (CIG). The heat map shows log~10~ fragments per kilobase per million reads mapped (FPKM) values for 52 selected genes indicated by tick marks in Figure [3](#OFV093F3){ref-type="fig"} (rows) and 32 samples (columns). Color corresponds to per-gene z-score that is computed from log~10~ FPKM (after adding 0.01). Genes and samples were hierarchically clustered based on Jensen-Shannon divergence distance using non-log FPKM data (after adding 1) and average linkage (dendrogram not shown for genes). Abbreviation: CC, clonal complex. Figure 5.Multidimensional scaling of transcriptome data for the *Staphylococcus aureus* Complicated Infection Group (CIG) isolates and reference strains. Multidimensional scaling was performed using a Jensen-Shannon divergence sample-sample distance matrix using fragments per kilobase per million reads mapped (+1) values for 2807 available genes. The first 2 coordinates are shown. Circles are CIG isolates from complicated infections and triangles are healthy controls (nasal carriage isolates). Clonal complex is indicated by color (see key). Reference *S aureus* strains (UAMS-1, MRSA252, and N315) are black asterisks.

DISCUSSION {#s4}
==========

Previous studies have shown that the *S aureus* CC30 lineage is associated with an increased risk for hematogenous complicated infections, including endocarditis, septic arthritis, vertebral osteomyelitis \[[@OFV093C8], [@OFV093C14], [@OFV093C15]\], and persistent bacteremia \[[@OFV093C30]\]. The current study sought to evaluate this association by genotype and severity of infections using in vivo infection models, comparative genome sequencing, and transcriptome analysis.

One intriguing finding from this study is the diminished virulence phenotype of the CC30 isolates in the animal sepsis models. This outcome is in variance with our previous results showing an association of CC30 with severe human infections \[[@OFV093C8]\], but it is in agreement with a recent report from DeLeo et al \[[@OFV093C17]\] where contemporary CC30 isolates displayed attenuated virulence in mouse sepsis model. The underlying basis for these differences can be attributed to either the host background or virulence potential of the CC30 isolates. Infections caused by CC30 occurred in a hospital setting, with individuals having existing risk factors for infection. The association of CC30 with bloodstream infections and persistent bacteremia suggests that they are adapted to long-term colonization and persistence, resulting in a high colonization burden in the human host \[[@OFV093C8], [@OFV093C31]\]. This is supported by recent data from Cheung et al \[[@OFV093C29]\], who demonstrates that the SNP in CC30 PSMα3 contributes to an attenuated proinflammatory potential in this lineage. The variance can also be attributed use of the mouse as a surrogate for human infections. The cardiovascular physiology of mice is distinct from humans, which compromises their use as models to assess pathogenesis and mechanisms of immune protection against *S aureus* infection. Future studies will use a rabbit model, whose immune and cardiovascular systems are more similar to humans \[[@OFV093C32]\].

The JOC analysis demonstrated that the CC30 isolates possess a distinct set of core proteins, with 25 proteins uniquely associated with CC30 isolates. Examples include a nitric oxide reductase (Nor) and fatty acid desaturase (Fad), which likely contribute to protection against production of radical nitric oxide (NO) by activated phagocytes and changes in membrane fluidity, respectively. CC30 Nor is a homolog of *Neisseria meningitides* MC58 *norB*, which is essential for persistence in the nasopharynx and evasion of macrophage response \[[@OFV093C33]\]. All lineages of *S aureus* are capable of metabolically adjusting to nitrosative stress by expressing an NO-inducible [l]{.smallcaps}-lactate dehydrogenase (*ldh1*) and a NO-detoxifying flavohemoglobin (*hmp*) and do not require Nor for this protective response \[[@OFV093C34]\]. However, recent work by Lewis et al \[[@OFV093C35]\] on CC30 Nor suggests that it contributes to NO-dependent respiration during nitrosative stress, potentially enhancing protection from NO in the CC30 lineage. The *S* aureus Fad is a homolog of a fatty acid desaturase from *Bacillus subtilis*, Des, which is involved in membrane adaptation during cold shock, decreased daptomycin susceptibility, and contributes to long-term survival in vitro \[[@OFV093C36]\]. In a similar manner, the *S aureus* Fad may play a role in maintaining membrane functions and contribute to the development of persistent infections. It is noteworthy that homologs of Fad are found in isolates of *S epidermidis* and *Staphylococcus capitis,* suggesting that *fad* was acquired through lateral gene transfer from these commensal staphylococcal species associated with endocarditis and bloodstream infections \[[@OFV093C37], [@OFV093C38]\]. Functional characterization of CC30 strains with targeted deletions of *fad* is needed to determine its role in multiple staphylococcal species.

The potential association between the transcriptome of CIG CC30 isolates to virulence and fitness were assessed by RNA-Seq transcriptome analysis of the 29 CIG isolates and reference strains MRSA252, N315, and UAMS-1. The CC30 isolates segregated into a transcriptome cluster that is distinct from all other CCs (Figure [5](#OFV093F5){ref-type="fig"}), which suggests that the transcriptome is a distinguishing feature of the CC30 that contributes to the attenuated virulence and persistence of this lineage. It is noteworthy that UAMS-1, a commonly used laboratory strain of CC30, has transcriptional features distinct from the CIG CC30 clinical isolates. A significant feature of the CC30 transcriptome is increased expression of protein A, a consequence of *agr*C~G55R~ and defective Agr global regulatory system. Binding of protein A to different subclasses of immunoglobulins inhibits the B-cell responses during infection, interferes with the development of protective immunity \[[@OFV093C39]--[@OFV093C41]\], and leads to the overall immune suppression against staphylococcal infections \[[@OFV093C42]\]. A diminished immune response in healthcare-associated *S aureus* infections may contribute to persistence and survival of CC30, leading to chronic complicated infections \[[@OFV093C17]\].

Down-regulation of genes in the pyrimidine biosynthetic pathway (*carB*, *pyrR*, *pyrE*, and *pyrF*) (Figure [4](#OFV093F4){ref-type="fig"}) and subsequent decreases in levels of thymidine in the CC30 lineage are suggestive of thymidine-dependent small colony variants (SCVs) \[[@OFV093C43]\]. Other aspects of CC30 that are similar to thymidine-dependent SCVs include an Agr negative phenotype and increased levels of protein A. Thymidine-dependent SCVs also have decreased levels of *hla* transcription, whereas the *hla* in CC30 has a stop codon at amino acid (Glutamine 113: Q113Stop), making it nonfunctional. Our analysis suggests that the CC30 lineage shares some of the key metabolic features of SCVs and may be able to more quickly transition to a SCV-like bacterium.

CONCLUSIONS {#s5}
===========

In summary, we have previously demonstrated that the CC30 lineage is distinguished by its ability to persist in the human host where it can initiate complicated infections such as infectious endocarditis and osteomyelitis. The inability of CC30 to cause sepsis-induced mortality in animal models suggests that this lineage has acquired genetic features including increased expression of protein A, which, in concert with the accumulation of SNPs in several virulence genes and regulators (eg, *agrC*, *hla*, *psmα3*), may be of strategic significance for CC30 isolates to better persist in and colonize the human host by escaping the immune response and attenuating its virulence until the conditions become favorable for bacteremia and subsequent hematogenous seeding. In addition, genes unique to CC30 such as *nor* and *fad* and decreased expression of metabolic genes responsible for production of SCVs may contribute to immune evasion and long-term survival of these strains in the endocardial and osteoarticular host environments. Further analysis, including transcriptome profiling using in vivo models and functional analysis of the genes unique to CC30, is needed to validate the molecular mechanisms responsible for the persistent phenotype.
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[^1]: Present Affiliation: Scripps Green Hospital, Scripps Clinic, Internal Medicine, La Jolla, California.

[^2]: Abbreviations: B&J, bone and joint infection; Both, both bone and joint and endocarditis; CIG, Complicated Infection Group; Endo, endocarditis; ID, identification.

[^3]: ^a^ Sequence data for the CIG genomes has been deposited in GenBank under PID (Pathway Interaction Database):

[^4]: ^b^ 1, cured; 2, recurrent *S aureus* infection; 3, death due to *S aureus* infection.

[^5]: ^c^ Proportion of 14 potential virulence genes more frequently associated with strains causing complicated infections \[[@OFV093C14]\]. This value is a fraction determined by X/14, where X = the number of virulence genes in the isolate.

[^6]: PRJNA60651, PRJNA60653, PRJNA60655, PRJNA60657, PRJNA60659, PRJNA60661, PRJNA60663, PRJNA60665, PRJNA60667, PRJNA60669, PRJNA60671, PRJNA60673, PRJNA60675, PRJNA60677, PRJNA60679, PRJNA60681, PRJNA60683, PRJNA60685, PRJNA60687, PRJNA60689, PRJNA60691, PRJNA60693, PRJNA60695, PRJNA60697, PRJNA60699, PRJNA60701, PRJNA60703, PRJNA60705, PRJNA60707.

[^7]: Abbreviations: CIG, Complicated Infection Group; ID, identification.

[^8]: ^a^ Average number of proteins in cluster was determined by X/11, where X = total number of proteins in clusters identified in all CC30 included in the comparison and 11 = total number of CC30 isolates included in the comparison ([Supplementary Table 2](http://ofid.oxfordjournals.org/lookup/suppl/doi:10.1093/ofid/ofv093/-/DC1)).

[^9]: ^b^ +, within genomic islets of MRSA252.

[^10]: ^c^ A, not in MRSA252.
